BIOSYNTIA ApS: Financial statements 2022
CVR: 34892970
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -16,583,471 and a net result of DKK -26,434,976 compared with DKK -10,062,482 the year before. Equity in the 2022 report amounted to DKK 101,266,486. The solvency ratio was 83%. The company had 19 employees in the financial year.
- Gross Profit
- DKK -16,583,471
- Profit/Loss
- DKK -26,434,976
- Equity
- DKK 101,266,486
- Total Assets
- DKK 122,005,610
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -16.6 mio. | -26.4 mio. | 101.3 mio. | 19 |
| 2021 | - | 1.2 mio. | -10.1 mio. | 16.2 mio. | 17 |
| 2020 | - | 818 t. | -9.4 mio. | 26.2 mio. | 21 |
| 2019 | - | 439 t. | -8.2 mio. | 16.9 mio. | 20 |
| 2018 | - | -2.7 mio. | -9.4 mio. | 25.2 mio. | 18 |
Official annual report
Keep an eye on BIOSYNTIA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of September 30, 2022, Sara Sande has joined the board of directors of BIOSYNTIA ApS.
As of September 30, 2022, is registered as an owner of BIOSYNTIA ApS with an ownership share of 5%.
As of June 20, 2022, Michael Jean Nettersheim has joined the board of directors of BIOSYNTIA ApS.
As of June 20, 2022, Morten Otto Alexander Sommer has left the board of directors of BIOSYNTIA ApS.
As of June 20, 2022, Novo Holdings A/S is registered as an owner of BIOSYNTIA ApS with an ownership share of 33%.
As of June 20, 2022, is registered as an owner of BIOSYNTIA ApS with an ownership share of 25%.
As of June 20, 2022, is registered as an owner of BIOSYNTIA ApS with an ownership share of 10%.
BIOSYNTIA ApS has published its annual report for 2021. Gross profit came to DKK 1,167,480, and the net result was DKK -10,062,482.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The board consists of Henrik Dalbøge (chair), Joško Bobanović and Thomas Grotkjær. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees (2018). In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity in the 2025 report amounted to DKK 32,860,576.